Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
ACS Med Chem Lett
2010 Jul 20;18:422-6. doi: 10.1021/ml100125f.
Show Gene links
Show Anatomy links
Exploring α7-Nicotinic Receptor Ligand Diversity by Scaffold Enumeration from the Chemical Universe Database GDB.
Garcia-Delgado N
,
Bertrand S
,
Nguyen KT
,
van Deursen R
,
Bertrand D
,
Reymond JL
.
???displayArticle.abstract???
Virtual analogues (1167860 compounds) of the nicotinic α7-receptor (α7 nAChR) ligands PNU-282,987 and SSR180711 were generated from the chemical universe database GDB-11 by extracting all aliphatic diamine analogues of the aminoquinuclidine and 1,4-diazabicyclo[3.2.2]nonane scaffolds of these ligands and converting them to the corresponding aryl amides using five different aromatic acyl groups. The library was ranked by docking to the nicotinic binding site of the acetylcholine binding protein (AChBP, 1UW6.pdb) using Autodock and Glide. Thirty-eight ligands derived from the best docking hits were synthesized and tested for modulation of the acetylcholine signal at the human α7 nAChR receptor expressed in Xenopus oocytes, leading to competitive and noncompetitive antagonists with IC50 = 5-7 μM. These experiments demonstrate the first example of using GDB in a fragment-based approach by diversifying the scaffold of known drugs.
Billingsley,
Druggable targets and targeted drugs: enhancing the development of new therapeutics.
2008, Pubmed
Billingsley,
Druggable targets and targeted drugs: enhancing the development of new therapeutics.
2008,
Pubmed
Biton,
SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile.
2007,
Pubmed
,
Xenbase
Blum,
970 million druglike small molecules for virtual screening in the chemical universe database GDB-13.
2009,
Pubmed
Bodnar,
Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors.
2005,
Pubmed
Celie,
Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures.
2004,
Pubmed
Congreve,
Recent developments in fragment-based drug discovery.
2008,
Pubmed
Feuerbach,
The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain.
2009,
Pubmed
Fink,
Virtual exploration of the small-molecule chemical universe below 160 Daltons.
2005,
Pubmed
Fink,
Virtual exploration of the chemical universe up to 11 atoms of C, N, O, F: assembly of 26.4 million structures (110.9 million stereoisomers) and analysis for new ring systems, stereochemistry, physicochemical properties, compound classes, and drug discovery.
2007,
Pubmed
Friesner,
Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.
2004,
Pubmed
Hogg,
An automated system for intracellular and intranuclear injection.
2008,
Pubmed
,
Xenbase
Lipinski,
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.
2001,
Pubmed
Majchrzak,
[Derivatives of octahydrodiazocine-1,5 and octahydrodiazocine-1,4 with potential pharmacological action. I. Synthesis of N-alkyl derivatives of octahydrodiazocine-1,5 and octahydrodiazocine-1,4].
1975,
Pubmed
Nguyen,
Discovery of NMDA glycine site inhibitors from the chemical universe database GDB.
2008,
Pubmed
,
Xenbase
Nguyen,
3-(aminomethyl)piperazine-2,5-dione as a novel NMDA glycine site inhibitor from the chemical universe database GDB.
2009,
Pubmed
,
Xenbase
Oka,
Synthesis of 1-azabicyclo[3.3.0]octane derivatives and their effects as piracetam-like nootropics.
2000,
Pubmed
Paleari,
alpha7-Nicotinic receptor antagonists at the beginning of a clinical era for NSCLC and Mesothelioma?
2009,
Pubmed
Romanelli,
Central nicotinic receptors: structure, function, ligands, and therapeutic potential.
2007,
Pubmed
Rush,
A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction.
2005,
Pubmed
Schneider,
Voyages to the (un)known: adaptive design of bioactive compounds.
2009,
Pubmed
Suzuki,
N-[2-(1-azabicyclo[3.3.0]octan-5-yl)ethyl]-2-nitroaniline, a potent muscarinic agonist.
1997,
Pubmed
Taly,
Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system.
2009,
Pubmed
Ulens,
Use of acetylcholine binding protein in the search for novel alpha7 nicotinic receptor ligands. In silico docking, pharmacological screening, and X-ray analysis.
2009,
Pubmed
,
Xenbase
Walker,
Design, synthesis, structure-activity relationship, and in vivo activity of azabicyclic aryl amides as alpha7 nicotinic acetylcholine receptor agonists.
2006,
Pubmed
Wermuth,
Similarity in drugs: reflections on analogue design.
2006,
Pubmed
